» Articles » PMID: 12531874

Disruption of the CXCR4/CXCL12 Chemotactic Interaction During Hematopoietic Stem Cell Mobilization Induced by GCSF or Cyclophosphamide

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2003 Jan 18
PMID 12531874
Citations 267
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic progenitor cells (HPCs) normally reside in the bone marrow (BM) but can be mobilized into the peripheral blood (PB) after treatment with GCSF or chemotherapy. In previous studies, we showed that granulocyte precursors accumulate in the BM during mobilization induced by either GCSF or cyclophosphamide (CY), leading to the accumulation of active neutrophil proteases in this tissue. We now report that mobilization of HPCs by GCSF coincides in vivo with the cleavage of the N-terminus of the chemokine receptor CXCR4 on HPCs resident in the BM and mobilized into the PB. This cleavage of CXCR4 on mobilized HPCs results in the loss of chemotaxis in response to the CXCR4 ligand, the chemokine stromal cell-derived factor-1 (SDF-1/CXCL12). Furthermore, the concentration of SDF-1 decreased in vivo in the BM of mobilized mice, and this decrease coincided with the accumulation of serine proteases able to directly cleave and inactivate SDF-1. Since both SDF-1 and its receptor, CXCR4, are essential for the homing and retention of HPCs in the BM, the proteolytic degradation of SDF-1, together with that of CXCR4, could represent a critical step leading to the mobilization of HPCs into the PB in response to GCSF or CY.

Citing Articles

Comparative Study of Lipid Profile for Mice Treated with Cyclophosphamide by HPLC-HRMS and Bioinformatics.

Demicheva E, Polanco Espino F, Vedeneev P, Shevyrin V, Buhler A, Mukhlynina E Metabolites. 2025; 15(1).

PMID: 39852402 PMC: 11767742. DOI: 10.3390/metabo15010060.


Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies.

Xinyi Y, Vladimirovich R, Beeraka N, Satyavathi A, Kamble D, Nikolenko V Stem Cell Res Ther. 2024; 15(1):401.

PMID: 39506818 PMC: 11539620. DOI: 10.1186/s13287-024-04008-4.


Unraveling the interplay between inflammation and stem cell mobilization or homing: Implications for tissue repair and therapeutics.

Chang H, Liou Y, Sun D Tzu Chi Med J. 2024; 36(4):349-359.

PMID: 39421490 PMC: 11483098. DOI: 10.4103/tcmj.tcmj_100_24.


Mesenchymal Stem Cell and Hematopoietic Stem and Progenitor Cell Co-Culture in a Bone-Marrow-on-a-Chip Device toward the Generation and Maintenance of the Hematopoietic Niche.

Kefallinou D, Grigoriou M, Boumpas D, Tserepi A Bioengineering (Basel). 2024; 11(8).

PMID: 39199706 PMC: 11352072. DOI: 10.3390/bioengineering11080748.


Development of VLA4 and CXCR4 Antagonists for the Mobilization of Hematopoietic Stem and Progenitor Cells.

Ruminski P, Rettig M, Dipersio J Biomolecules. 2024; 14(8).

PMID: 39199390 PMC: 11353233. DOI: 10.3390/biom14081003.


References
1.
Brelot A, Heveker N, Montes M, Alizon M . Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem. 2000; 275(31):23736-44. DOI: 10.1074/jbc.M000776200. View

2.
Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V . The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 2000; 95(11):3289-96. View

3.
Ponomaryov T, Peled A, Petit I, Taichman R, Habler L, Sandbank J . Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest. 2000; 106(11):1331-9. PMC: 381461. DOI: 10.1172/JCI10329. View

4.
Delgado M, Clark-Lewis I, Loetscher P, Langen H, Thelen M, Baggiolini M . Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol. 2001; 31(3):699-707. DOI: 10.1002/1521-4141(200103)31:3<699::aid-immu699>3.0.co;2-6. View

5.
Koni P, Joshi S, Temann U, Olson D, Burkly L, Flavell R . Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001; 193(6):741-54. PMC: 2193418. DOI: 10.1084/jem.193.6.741. View